Minerva Surgical, Inc.
UTRS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $50 | $52 | $38 | $26 |
| % Growth | -3.5% | 38% | 45.2% | – |
| Cost of Goods Sold | $23 | $22 | $19 | $14 |
| Gross Profit | $27 | $31 | $19 | $12 |
| % Margin | 54.2% | 58.6% | 50.6% | 45.4% |
| R&D Expenses | $5 | $5 | $3 | $1 |
| G&A Expenses | $14 | $22 | $8 | $8 |
| SG&A Expenses | $53 | $54 | $31 | $31 |
| Sales & Mktg Exp. | $38 | $32 | $23 | $22 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $58 | $60 | $35 | $31 |
| Operating Income | -$31 | -$29 | -$15 | -$20 |
| % Margin | -61.4% | -55.9% | -40.7% | -75.5% |
| Other Income/Exp. Net | -$3 | $8 | -$3 | -$32 |
| Pre-Tax Income | -$34 | -$21 | -$18 | -$52 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$34 | -$21 | -$18 | -$52 |
| % Margin | -67.8% | -41.2% | -48.4% | -200.1% |
| EPS | -23.68 | -14.98 | -17.91 | -75.29 |
| % Growth | -58.1% | 16.4% | 76.2% | – |
| EPS Diluted | -23.68 | -14.98 | -17.91 | -75.29 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $12 | $12 | $18 |
| Depreciation & Amortization | $11 | $11 | $7 | $2 |
| EBITDA | -$20 | $1 | $1 | -$18 |
| % Margin | -39.9% | 1.7% | 2.2% | -67.9% |